Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3538) 3538
Publication (395) 395
Book Review (34) 34
Book Chapter (24) 24
Conference Proceeding (8) 8
Dissertation (4) 4
Data Set (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
transarterial chemoembolization (2961) 2961
hepatocellular carcinoma (2046) 2046
humans (1939) 1939
index medicus (1928) 1928
male (1287) 1287
liver neoplasms - therapy (1236) 1236
female (1223) 1223
middle aged (1133) 1133
carcinoma, hepatocellular - therapy (1094) 1094
aged (994) 994
treatment outcome (928) 928
oncology (920) 920
survival (847) 847
cancer (821) 821
liver cancer (818) 818
transcatheter arterial chemoembolization (812) 812
gastroenterology & hepatology (809) 809
hepatoma (780) 780
liver neoplasms - pathology (780) 780
radiology, nuclear medicine & medical imaging (718) 718
carcinoma, hepatocellular - pathology (704) 704
adult (671) 671
radiofrequency ablation (619) 619
liver (614) 614
care and treatment (598) 598
retrospective studies (597) 597
chemoembolization, therapeutic - methods (577) 577
liver neoplasms - mortality (551) 551
prognosis (550) 550
carcinoma, hepatocellular - mortality (513) 513
surgery (496) 496
chemoembolization, therapeutic (486) 486
embolization (475) 475
sorafenib (467) 467
therapy (425) 425
aged, 80 and over (423) 423
management (410) 410
chemotherapy (396) 396
medicine & public health (394) 394
tumors (393) 393
hepatocellular-carcinoma (385) 385
liver neoplasms - surgery (357) 357
chemoembolization (355) 355
survival rate (355) 355
liver transplantation (337) 337
neoplasm staging (333) 333
carcinoma, hepatocellular - surgery (326) 326
risk factors (308) 308
analysis (297) 297
resection (296) 296
patients (290) 290
liver neoplasms - drug therapy (285) 285
combined modality therapy (284) 284
liver neoplasms - diagnostic imaging (279) 279
cirrhosis (278) 278
efficacy (273) 273
microspheres (273) 273
hepatectomy (272) 272
recurrence (267) 267
antineoplastic agents - administration & dosage (263) 263
chemoembolization, therapeutic - adverse effects (262) 262
liver-transplantation (259) 259
randomized controlled trial (259) 259
tace (259) 259
survival analysis (241) 241
drug-eluting beads (238) 238
carcinoma, hepatocellular - drug therapy (236) 236
ablation (234) 234
carcinoma, hepatocellular - diagnostic imaging (231) 231
radiotherapy (230) 230
randomized controlled-trial (224) 224
digestive system diseases (222) 222
hepatic resection (221) 221
time factors (221) 221
transplantation (220) 220
unresectable hepatocellular-carcinoma (217) 217
kaplan-meier estimate (216) 216
metastasis (212) 212
imaging / radiology (206) 206
doxorubicin (201) 201
radioembolization (198) 198
medical prognosis (197) 197
tomography, x-ray computed (196) 196
abridged index medicus (189) 189
antineoplastic agents - therapeutic use (189) 189
proportional hazards models (189) 189
radiology (188) 188
multivariate analysis (186) 186
percutaneous ethanol injection (185) 185
disease-free survival (183) 183
hcc (183) 183
follow-up studies (182) 182
liver neoplasms - diagnosis (180) 180
magnetic resonance imaging (179) 179
animals (176) 176
health aspects (175) 175
prognostic-factors (175) 175
ultrasound (172) 172
diagnosis (168) 168
doxorubicin - administration & dosage (168) 168
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3261) 3261
Korean (146) 146
German (97) 97
French (23) 23
Spanish (16) 16
Japanese (9) 9
Italian (4) 4
Czech (3) 3
Icelandic (2) 2
Polish (2) 2
Turkish (2) 2
Chinese (1) 1
Croatian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization–Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors ≤5 cm: A Propensity Analysis at a Single Center
by Chen, Qi-Feng and Jia, Zhen-Yu and Yang, Zheng-Qiang and Fan, Wen-Long and Shi, Hai-Bin
CardioVascular and Interventional Radiology, ISSN 0174-1551, 11/2017, Volume 40, Issue 11, pp. 1748 - 1755
To compare effectiveness of transarterial chemoembolization (TACE) combined with microwave ablation (MWA; TACE–MWA) with TACE alone for treating hepatocellular... 
Microwave ablation | Medicine & Public Health | Transarterial chemoembolization | Hepatocellular carcinoma | Nuclear Medicine | Imaging / Radiology | Cardiology | Propensity analysis | Ultrasound | 5 cm | SURVIVAL | CRITERIA | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | HEPATECTOMY | 5 cm | RANDOMIZED CONTROLLED TRIAL | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RADIOFREQUENCY ABLATION | Follow-Up Studies | Humans | Middle Aged | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Male | Treatment Outcome | Liver Neoplasms - therapy | Chemoembolization, Therapeutic - methods | Propensity Score | Ablation Techniques - methods | Female | Carcinoma, Hepatocellular - therapy | Retrospective Studies | Liver - surgery | Microwaves | Antimitotic agents | Ablation (Surgery) | Care and treatment | Analysis | Development and progression | Hepatoma | Antineoplastic agents | Cancer | Liver cancer | Gangrene | Solid tumors | Ablation | Patients | Tumors | Necrosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Transcatheter arterial chemoembolization monotherapy vs combined transcatheter arterial chemoembolization–percutaneous microwave coagulation therapy for massive hepatocellular carcinoma (≥10 cm)
by Wei, Yanyan and Dai, Feng and Zhao, Tianhui and Tao, Chen and Wang, Lili and Ye, Wei and Zhao, Wei
Cancer Management and Research, ISSN 1179-1322, 2018, Volume 10, pp. 5273 - 5282
Background: The prognosis of massive hepatocellular carcinomas (MHCCs; >= 10 cm) remains worse. Purpose: The aim of this study was to evaluate the clinical... 
TACE | PMCT | Percutaneous microwave coagulation therapy | Transcatheter arterial chemoembolization | Massive hepatocellular carcinoma | transcatheter arterial chemoembolization | PROGNOSTIC-FACTORS | ALPHA-FETOPROTEIN LEVELS | PHASE-II | HCC | massive hepatocellular carcinoma | LIVER-CANCER | THERMAL ABLATION | percutaneous microwave coagulation therapy | ONCOLOGY | TRANSARTERIAL CHEMOEMBOLIZATION | TUMOR SIZE | RADIOFREQUENCY ABLATION | Usage | Prognosis | Hepatoma | Arterial catheterization | Hypertension | Nuclear magnetic resonance--NMR | Medical imaging | Transplants & implants | Laboratories | Mortality | Family medical history | Metastasis | Medical diagnosis | Patients | Cancer therapies | Liver cancer | Hepatitis | Medical prognosis | Diabetes | Veins & arteries
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Chemoembolization for hepatocellular carcinoma
by Bruix, Jordi and Sala, Margarita and Llovet, Josep M
Gastroenterology, ISSN 0016-5085, 2004, Volume 127, Issue 5, pp. S179 - S188
Curative therapies for hepatocellular carcinoma (HCC), such as resection, liver transplantation, and percutaneous ablation, can be applied in selected patients... 
TRANSCATHETER ARTERIAL EMBOLIZATION | OILY CHEMOEMBOLIZATION | CISPLATIN | TRANSARTERIAL EMBOLIZATION | PERCUTANEOUS ETHANOL INJECTION | RANDOMIZED CLINICAL-TRIAL | LIPIODOL CHEMOEMBOLIZATION | LIVER | LYMPHOGRAPHIC AGENT | GASTROENTEROLOGY & HEPATOLOGY | SYMPTOMATIC TREATMENT | Chemoembolization, Therapeutic - methods | Prognosis | Neoplasm Invasiveness | Humans | Survival Analysis | Liver - physiology | Chemoembolization, Therapeutic - adverse effects | Carcinoma, Hepatocellular - therapy | Liver Neoplasms - therapy | Neoplasm Staging | Patient Selection | Transplantation of organs, tissues, etc | Liver cancer | Chemotherapy | Hepatoma | Analysis | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Chemoembolization for hepatocellular carcinoma
by Lencioni, Riccardo
Seminars in Oncology, ISSN 0093-7754, 08/2012, Volume 39, Issue 4, pp. 503 - 509
Transcatheter arterial chemoembolization (TACE) is the standard of care for patients with preserved liver function and asymptomatic, noninvasive multinodular... 
RANDOMIZED CONTROLLED TRIAL | REGIONAL TREATMENT | MODIFIED RECIST | SOLID TUMORS | ONCOLOGY | ARTERIAL EMBOLIZATION | RESPONSE EVALUATION CRITERIA | LIPIODOL CHEMOEMBOLIZATION | TRANSARTERIAL CHEMOEMBOLIZATION | CLINICAL-PRACTICE | SYMPTOMATIC TREATMENT | Chemoembolization, Therapeutic - methods | Carcinoma, Hepatocellular - therapy | Liver Neoplasms - therapy | Humans | Randomized Controlled Trials as Topic | Index Medicus
Journal Article
Details down arrow
5. Full Text Transarterial Chemoembolization and Radioembolization
by Sangro, Bruno and Salem, Riad
Seminars in Liver Disease, ISSN 0272-8087, 11/2014, Volume 34, Issue 4, pp. 435 - 443
Abstract Transarterial chemoembolization (TACE) and radioembolization (RE) are frequently used to treat patients with hepatocellular carcinoma who cannot... 
radioembolization | selective internal radiation therapy | yttrium | transarterial chemoembolization | drug-eluting bead transarterial chemoembolization | DRUG-ELUTING BEADS | PORTAL-VEIN | PREDISPOSING FACTORS | SURVIVAL ANALYSIS | TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION | RESIN MICROSPHERES | UNRESECTABLE HEPATOCELLULAR-CARCINOMA | TUMOR RESPONSE | 5-YEAR SURVIVAL | GASTROENTEROLOGY & HEPATOLOGY | Y-90 MICROSPHERES | Humans | Treatment Outcome | Liver Neoplasms - therapy | Embolization, Therapeutic - adverse effects | Patient Selection | Liver Neoplasms - blood supply | Carcinoma, Hepatocellular - pathology | Carcinoma, Hepatocellular - blood supply | Chemoembolization, Therapeutic - adverse effects | Liver Neoplasms - pathology | Carcinoma, Hepatocellular - therapy | Radiopharmaceuticals - adverse effects | Embolization, Therapeutic - methods | Radiopharmaceuticals - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Large primary hepatocellular carcinoma: Transarterial chemoembolization monotherapy versus combined transarterial chemoembolization‐percutaneous microwave coagulation therapy
by Xu, Lin‐Feng and Sun, Hong‐Liang and Chen, Yao‐Ting and Ni, Jia‐Yan and Chen, Dong and Luo, Jiang‐Hong and Zhou, Jing‐Xing and Hu, Ren‐Mei and Tan, Qi‐Yun
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 03/2013, Volume 28, Issue 3, pp. 456 - 463
Background and Aim To evaluate the clinical benefits of transarterial chemoembolization (TACE) monotherapy or TACE combined with percutaneous microwave... 
transarterial chemoembolization (TACE) | hepatocellular carcinoma (HCC) | percutaneous microwave coagulation therapy (PMCT) | log–rank tests | overall survival (OS) | the median survival time | Overall survival (OS) | Transarterial chemoembolization (TACE) | Percutaneous microwave coagulation therapy (PMCT) | The median survival time | Log-rank tests | Hepatocellular carcinoma (HCC) | THERMAL ABLATION | MANAGEMENT | EMBOLIZATION | COMBINATION THERAPY | TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION | GASTROENTEROLOGY & HEPATOLOGY | log-rank tests | Carcinoma, Hepatocellular - mortality | Radiography, Interventional | Follow-Up Studies | Humans | Middle Aged | Male | Liver Neoplasms - therapy | Antineoplastic Agents - administration & dosage | Liver Neoplasms - mortality | Carcinoma, Hepatocellular - diagnostic imaging | Chemoembolization, Therapeutic - methods | Adult | Female | Liver Neoplasms - pathology | Retrospective Studies | Multidetector Computed Tomography | Kaplan-Meier Estimate | Survival Rate | Treatment Outcome | Combined Modality Therapy | Tumor Burden | Liver Neoplasms - diagnostic imaging | Ablation Techniques - methods | Carcinoma, Hepatocellular - pathology | Aged | Carcinoma, Hepatocellular - therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. The value of [11C]-acetate PET and [18F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab
by Li, Shuren and Peck-Radosavljevic, Markus and Ubl, Philipp and Wadsak, Wolfgang and Mitterhauser, Markus and Rainer, Eva and Pinter, Matthias and Wang, Hao and Nanoff, Christian and Kaczirek, Klaus and Haug, Alexander and Hacker, Marcus
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 09/2017, Volume 44, Issue 10, pp. 1732 - 1741
Purpose This prospective study was to investigate the value of [C-11]-acetate PET and [F-18]-FDG PET in the evaluation of hepatocellular carcinoma (HCC) before... 
FDG | Hepatocellular carcinoma | Acetate | Transarterial chemoembolization | Pet | Bevacizumab | TUMOR RECURRENCE | LIVER-TRANSPLANTATION | CANCER | PREDICTION | TRIAL | POSITRON-EMISSION-TOMOGRAPHY | THERAPY | F-18-FDG | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ENDOTHELIAL GROWTH-FACTOR | Bevacizumab - therapeutic use | Bevacizumab - administration & dosage | Chemoembolization, Therapeutic | Humans | Middle Aged | Male | Treatment Outcome | Liver Neoplasms - therapy | Positron-Emission Tomography | Acetates | Carbon | Liver Neoplasms - diagnostic imaging | Arteries | Carcinoma, Hepatocellular - diagnostic imaging | Survival Analysis | Female | Fluorodeoxyglucose F18 | Aged | Carcinoma, Hepatocellular - therapy | Patients | Cancer therapies | Clinical outcomes | Heterogeneity | Liver cancer | Histopathology | Men | Tomography | Death | Lesions | Vascular endothelial growth factor
Journal Article
Details down arrow
8. Full Text Magnetic resonance imaging features predictive of an incomplete response to transarterial chemoembolization in patients with hepatocellular carcinoma: A STROBE-compliant study
by Kim, Yeun Jeong and Lee, Min Hee and Choi, Seo Youn and Yi, Boem Ha and Lee, Hae Kyung
Medicine, ISSN 0025-7974, 05/2019, Volume 98, Issue 19, p. e15592
To identify pretreatment magnetic resonance imaging (MRI) features associated with an incomplete response (IR) to transarterial chemoembolization (TACE) in... 
SURVIVAL | CRITERIA | DIAGNOSIS | PRACTICE GUIDELINES | MANAGEMENT | TUMOR | MEDICINE, GENERAL & INTERNAL | NODULES | IMPACT | EASL | LIVER | transarterial chemoembolization | hepatocellular carcinoma | imaging predictors | Prognosis | Follow-Up Studies | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Liver Neoplasms - therapy | Tumor Burden | Liver Neoplasms - diagnostic imaging | Carcinoma, Hepatocellular - diagnostic imaging | Chemoembolization, Therapeutic - methods | Magnetic Resonance Imaging | Female | Carcinoma, Hepatocellular - therapy | Retrospective Studies | Care and treatment | Usage | Therapeutic embolization | Hepatoma | Research | Magnetic resonance imaging
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
by Salem, Riad and Gordon, Andrew C and Mouli, Samdeep and Hickey, Ryan and Kallini, Joseph and Gabr, Ahmed and Mulcahy, Mary F and Baker, Talia and Abecassis, Michael and Miller, Frank and Yaghmai, Vahid and Sato, Kent and Desai, Kush and Thornburg, Bartley and Benson, Al B and Rademaker, Alfred and Ganger, Daniel and Kulik, Laura and Lewandowski, Robert J
Gastroenterology, ISSN 0016-5085, 2016, Volume 151, Issue 6, pp. 1155 - 1163.e2
Background & Aims Conventional transarterial chemoembolization (cTACE) is used to treat patients with hepatocellular carcinoma (HCC). Radioembolization is a... 
Gastroenterology and Hepatology | Randomized Trial | Liver Cancer | Radioembolization | Chemoembolization | SURVIVAL | RANDOMIZED-TRIALS | MICROSPHERES | EMBOLIZATION | SAFETY | CANCER | THERAPY | CLINICAL-TRIALS | TRANSARTERIAL CHEMOEMBOLIZATION | GASTROENTEROLOGY & HEPATOLOGY | Yttrium Radioisotopes - adverse effects | Liver Transplantation | Prospective Studies | Humans | Hypoalbuminemia - etiology | Middle Aged | Male | Survival Rate | Antineoplastic Agents - therapeutic use | Liver Neoplasms - therapy | Ethiodized Oil - therapeutic use | Disease Progression | Necrosis | Disease-Free Survival | Carcinoma, Hepatocellular - pathology | Intention to Treat Analysis | Chemoembolization, Therapeutic - adverse effects | Diarrhea - etiology | Female | Liver Neoplasms - pathology | Aged | Carcinoma, Hepatocellular - therapy | Neoplasm Staging | Yttrium Radioisotopes - therapeutic use | Rare earth metals | Continuing medical education | Care and treatment | Hepatoma | Comparative analysis | Medicine, Preventive | Preventive health services | radioembolization | liver cancer | chemoembolization | randomized trial
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Treatment of Small Hepatocellular Carcinoma (≤2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation
by Hyun, Dongho and Cho, Sung Ki and Shin, Sung Wook and Rhim, Hyunchul and Koh, Kwang Cheol and Paik, Seung Woon
CardioVascular and Interventional Radiology, ISSN 0174-1551, 7/2016, Volume 39, Issue 7, pp. 1015 - 1022
To evaluate technical feasibility and treatment results of sequential transcatheter arterial chemoembolization (TACE) and cone-beam computed tomography-guided... 
Transarterial chemoembolization/embolisation (TACE) | Interventional oncology | Medicine & Public Health | Combined treatments | Liver/hepatic | Hepatocellular carcinoma (HCC) | Radiofrequency ablation | Nuclear Medicine | Imaging / Radiology | Cardiology | Ultrasound | IODIZED OIL | MULTICENTER | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | GELATIN SPONGE | EMBOLIZATION | PIG MODEL | COMBINATION | LIVER | TRANSARTERIAL CHEMOEMBOLIZATION | COMPLICATIONS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Humans | Middle Aged | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Male | Treatment Outcome | Combined Modality Therapy | Liver Neoplasms - therapy | Feasibility Studies | Catheter Ablation - methods | Chemoembolization, Therapeutic - methods | Disease-Free Survival | Radiography, Interventional - methods | Liver - diagnostic imaging | Aged, 80 and over | Female | Aged | Carcinoma, Hepatocellular - therapy | Retrospective Studies | Liver - surgery | Cone-Beam Computed Tomography - methods | Care and treatment | Ablation (Surgery) | Ultrasound imaging | Development and progression | Hepatoma | Drug therapy | Cancer | REVIEWS | SURGERY | PATIENTS | HEPATOMAS | BEAMS | COMPUTERIZED TOMOGRAPHY | RADIOWAVE RADIATION | PROBABILITY | PLUTONIUM SULFIDES | RADIOLOGY AND NUCLEAR MEDICINE | ABLATION | ULTRASONOGRAPHY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
by Kloeckner, Roman and Weinmann, Arndt and Prinz, Friederike and Pinto dos Santos, Daniel and Ruckes, Christian and Dueber, Christoph and Pitton, Michael Bernhard
BMC Cancer, ISSN 1471-2407, 12/2015, Volume 15, Issue 1, p. 465
Background: To compare the overall survival of patients with hepatocellular carcinoma (HCC) who were treated with lipiodol-based conventional transarterial... 
Drug-eluting bead transarterial chemoembolization (DEB-TACE) | Conventional transarterial chemoembolization (cTACE) | Hepatocellular carcinoma (HCC) | SURVIVAL | DEB | LIVER-TRANSPLANTATION | PROGNOSIS | DOXORUBICIN | TACE | RANDOMIZED CONTROLLED-TRIAL | HISTOLOGICAL GRADE | IMPACT | ONCOLOGY | ARTERIAL EMBOLIZATION | Humans | Middle Aged | Liver Neoplasms - drug therapy | Male | Chemoembolization, Therapeutic - methods | Ethiodized Oil - administration & dosage | Liver Transplantation - methods | Carcinoma, Hepatocellular - drug therapy | Carcinoma, Hepatocellular - pathology | Adult | Female | Liver Neoplasms - pathology | Aged | Doxorubicin - administration & dosage | Liver cancer | Chemotherapy | Usage | Patient outcomes | Hepatoma | Drug therapy | Health aspects | Stent (Surgery) | Cancer | Online searching | Internet/Web search services | Database searching
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Chemoembolization and radioembolization
by Sangro, Bruno, MD, PhD
Best Practice & Research: Clinical Gastroenterology, ISSN 1521-6918, 2014, Volume 28, Issue 5, pp. 909 - 919
Abstract Chemoembolization and radioembolization are at the core of the treatment of patients with hepatocellular carcinoma who cannot receive potentially... 
Gastroenterology and Hepatology | Radioembolization, RE | Yttrium | Transarterial chemoembolization, TACE | Drug-eluting beads, DEB | Selective Internal Radiation Therapy, SIRT | DEB | Selective internal radiation therapy | Transarterial chemoembolization | TACE | Drug-eluting beads | Radioembolization | SIRT | DRUG-ELUTING BEADS | Y-90 MICROSPHERES THERASPHERE(R) | PORTAL-VEIN | PREDISPOSING FACTORS | SURVIVAL ANALYSIS | TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION | UNRESECTABLE HEPATOCELLULAR-CARCINOMA | SUPERSELECTIVE TRANSARTERIAL CHEMOEMBOLIZATION | LIVER-CANCER | 5-YEAR SURVIVAL | GASTROENTEROLOGY & HEPATOLOGY | Radiopharmaceuticals - administration & dosage | Carcinoma, Hepatocellular - therapy | Liver Neoplasms - therapy | Antineoplastic Agents - administration & dosage | Humans | Embolization, Therapeutic - methods
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Chemoembolization Combined With Radiofrequency Ablation for Patients With Hepatocellular Carcinoma Larger Than 3 cm: A Randomized Controlled Trial
by Cheng, Bao-Quan and Jia, Chong-Qi and Liu, Chun-Tao and Fan, Wei and Wang, Qing-Liang and Zhang, Zong-Li and Yi, Cui-Hua
JAMA, ISSN 0098-7484, 04/2008, Volume 299, Issue 14, pp. 1669 - 1677
This article has been retracted. See Notice of Retraction. CONTEXT Transarterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) therapy... 
MEDICINE, GENERAL & INTERNAL | THERMAL ABLATION | THERAPY | MANAGEMENT | ETHANOL INJECTION | ARTERIAL EMBOLIZATION | LIPIODOL CHEMOEMBOLIZATION | TRANSARTERIAL CHEMOEMBOLIZATION | VALIDATION | HCC | CLIP SCORE | Chemoembolization, Therapeutic | Humans | Middle Aged | Hepatic Artery | Catheter Ablation | Male | Survival Rate | Combined Modality Therapy | Liver Neoplasms - therapy | Antineoplastic Agents - administration & dosage | Cisplatin - administration & dosage | Carcinoma, Hepatocellular - pathology | Female | Liver Neoplasms - pathology | Aged | Carcinoma, Hepatocellular - therapy | Evaluation | Care and treatment | Usage | Ultrasound imaging | Combined modality therapy | Radiofrequency ablation | Research | Hepatoma | Health aspects | Chemotherapy | Liver | Mortality | Clinical trials | Oncology | Radiation therapy | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Chemoembolization of Hepatocellular Carcinoma
by Ramsey, Douglas E and Kernagis, Lily Y and Soulen, Michael C and Geschwind, Jean-Francois H
Journal of Vascular and Interventional Radiology, ISSN 1051-0443, 2002, Volume 13, Issue 9, pp. S211 - S221
Transcatheter arterial chemoembolization (TACE) is the mainstay of treatment for patients with unresectable hepatocellular carcinoma (HCC). Chemoembolization... 
Liver neoplasms, therapeutic radiology | Liver neoplasms, chemotherapeutic infusion | PROGNOSTIC FACTORS | IODIZED OIL | LIVER-TRANSPLANTATION | OILY CHEMOEMBOLIZATION | TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION | liver neoplasms, chemotherapeutic infusion | RANDOMIZED TRIAL | liver neoplasms, therapeutic radiology | PERCUTANEOUS ETHANOL INJECTION | TRANSARTERIAL CHEMOEMBOLIZATION | PERIPHERAL VASCULAR DISEASE | CIRRHOTIC-PATIENTS | QUALITY-OF-LIFE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiography, Interventional | Liver Neoplasms - diagnosis | Prognosis | Carcinoma, Hepatocellular - diagnosis | Chemoembolization, Therapeutic | Humans | Neoadjuvant Therapy | Treatment Outcome | Carcinoma, Hepatocellular - therapy | Liver Neoplasms - therapy | Antineoplastic Agents - administration & dosage
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Transcatheter Arterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC): The Role of Angiogenesis and Invasiveness
by Sergio, Adriana and Cristofori, Chiara and Cardin, Romilda and Pivetta, Giorgio and Ragazzi, Roberto and Baldan, Anna and Girardi, Lisa and Cillo, Umberto and Burra, Patrizia and Giacomin, Anna and Farinati, Fabio
The American Journal of Gastroenterology, ISSN 0002-9270, 04/2008, Volume 103, Issue 4, pp. 914 - 921
OBJECTIVE: Although transcatheter arterial chemoembolization (TACE) is effective in hepatocellular carcinoma (HCC), it is not considered a curative procedure.... 
RANDOMIZED CONTROLLED TRIAL | PLASMINOGEN-ACTIVATOR | CIRRHOSIS | TRANSARTERIAL CHEMOEMBOLIZATION | PROGNOSTIC-SIGNIFICANCE | GASTROENTEROLOGY & HEPATOLOGY | PATIENT SURVIVAL | EXPRESSION | CANCER | ENDOTHELIAL GROWTH-FACTOR | CLINICAL-SIGNIFICANCE | Prognosis | Humans | Middle Aged | Neovascularization, Pathologic | Male | Liver Neoplasms - therapy | Epirubicin - administration & dosage | Iodized Oil - administration & dosage | Chemoembolization, Therapeutic - methods | Statistics, Nonparametric | Female | Liver Neoplasms - pathology | Urokinase-Type Plasminogen Activator - blood | Enzyme-Linked Immunosorbent Assay | Neoplasm Invasiveness | Proportional Hazards Models | Vascular Endothelial Growth Factor A - blood | Survival Rate | Lymphatic Metastasis | Fibroblast Growth Factor 2 - blood | Carcinoma, Hepatocellular - pathology | Aged | Carcinoma, Hepatocellular - therapy | Neoplasm Staging | Infusions, Intra-Arterial | Liver cancer | Care and treatment | Hepatoma | Neovascularization | Vascular endothelial growth factor | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights